Latest News

Common multiple sclerosis drugs taken together do not reduce relapse risk

A recent clinical trial found that interferonβ-1a (INF) and glatiramer acetate (GA), two of the most commonly prescribed drugs for multiple sclerosis (MS), provide no additional clinical benefit when taken together. While findings suggest that taking both INF and GA together was not superior to GA monotherapy in reducing relapse risk; the combination therapy does appear to reduce new lesion activity and total lesion volume.
View full story

Post your comment.


  • Mutation involved in neurodegeneration discovered

  • How dominant parents affect kids' self-worth

  • Virus-drug combination shows improved effectiveness against brain tumor cells

  • Risk profiling is key to managing pain in era of opioid abuse

  • Benzodiazepines ineffective in treating anxiety disorders may increase dementia risk

  • Immigrants play increasing role in U.S. science, engineering workforce

  • Scientists identify how normally protective immune responses kill neurons

  • Male suicide on rise as result of austerity, report suggests

  • Flu shot reduces risk of stroke, study suggests

  • Bankers suppress their identities to survive, thrive at work, finds study